Skip to content

News Category: Health & Medical

Nihon Medi-Physics Attains World’s First Manufacturing of Actinium-225 with Cyclotron on Production Scale for Investigational Drugs

By asianet

– Core Material Used for Targeted Alpha Therapy (TAT) Expected to Be Novel Treatment for Cancer – Nihon Medi-Physics Co., Ltd. (NMP), a leading radiopharmaceutical company in Japan, announced on April 5, 2022, that the company has successfully manufactured actinium-225 (Ac-225), a core material used for Targeted Alpha (*1) Therapy (TAT), on a GBq (*2) … Continued

MGC Pharmaceuticals Enters Partnership with Sciensus Rare for Distribution of Cannabinoids to Treat Refractory Epilepsy, Dementia and Alzheimer’s in the EU and UK

By asianet

MGC Pharmaceuticals Ltd. ( https://mgcpharma.com.au/ ) (LSE: MXC, ASX: MXC, OTC:MGCLF), a European based bio-pharma company specializing in the production and development of phytomedicines, has signed an exclusive distribution agreement with Sciensus Rare ( http://www.sciensusrare.com/ ), a part of UK health care group, Sciensus, for the distribution of CannEpil(R) and CogniCann(R) in key European territories … Continued

Formus Labs Adds Seasoned Medical Technology Executives Lloyd McCann and Meraj Khan to Board of Directors

By asianet

— Formus combines AI and biomechanics in fully automated preoperative planning workflows that empower orthopedic surgeons to optimize patient outcomes Formus Labs( https://c212.net/c/link/?t=0&l=en&o=3492393-1&h=1024423823&u=https%3A%2F%2Fwww.formuslabs.com%2F&a=%C2%A0Labs ), creator of the world’s first fully-automated 3D planner for joint replacement surgeries, today announced the appointments of Mercy Radiology and Clinics( https://c212.net/c/link/?t=0&l=en&o=3492393-1&h=3572573538&u=https%3A%2F%2Fradiology.co.nz%2F&a=Mercy+Radiology+and+Clinics ) CEO, Dr Lloyd McCann( https://c212.net/c/link/?t=0&l=en&o=3492393-1&h=1498015839&u=https%3A%2F%2Fwww.linkedin.com%2Fin%2Flloyd-mccann-493a4aa%2F&a=Lloyd+McCann ), and Vice … Continued

AMR Action Fund Announces First Investments in Adaptive Phage Therapeutics and Venatorx Pharmaceuticals

By asianet

— Deals mark an important step toward AMR Action Fund’s goal of bringing two to four new antibiotics to market to take on growing threat of drug-resistant bacteria The AMR Action Fund, the world’s largest public-private partnership investing in biotech companies that are developing antibiotics, announced today that it has invested in Adaptive Phage Therapeutics … Continued

International Virchow Prize for Global Health launched

By asianet

Highly prestigious award endowed with Euro 500,000 to uphold the United Nations 2030 Agenda – Picture is available at AP Images (http://www.apimages.com) – The nomination phase of the newly established Virchow Prize for Global Health has begun. This major international award honours outstanding achievements towards addressing today’s complex health challenges. The Prize is awarded annually … Continued

B.I.G. VISION(R) FOR ALL from Rodenstock: Optimal vision with biometric lenses for everyone

By asianet

Everyone’s appearance is so different and individual and so too are their eyes. Rodenstock recognised that every eye is different and developed an innovative technology that determines the personal biometrics of the eye from several thousand measuring points and incorporates these results directly into the manufacture of the lens. Biometric lenses from Rodenstock therefore offer … Continued

Radiaction Medical Ltd. Receives FDA Clearance for its Innovative Radiation Protection System and Secures $10M for US Launch and Commercialization

By asianet

Radiaction Medical Ltd. [ http://www.radiactionmedical.com/ ] (“Radiaction”), an innovative medical device company focused on radiation protection in the interventional cardiology and electrophysiology sectors, announced FDA 510(K) clearance for the marketing of its Shield System in the US. In addition, the company has completed a $10 million round of financing led by current investors, InnovaHealth Partners. … Continued

Pharming Announces Positive Data from Phase II/III Leniolisib Trial Presented at Clinical Immunology Society 2022 Annual Meeting

By asianet

Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam: PHARM/Nasdaq: PHAR) announces new data from the pivotal Phase II/III trial of leniolisib for the treatment of activated phosphoinositide 3-kinase delta (PI3K delta) syndrome (APDS), a primary immunodeficiency. Principal Investigator V. Koneti Rao, M.D., a staff physician in the Primary Immune Deficiency Clinic at the National … Continued

Airway Therapeutics Announces First Patient Dosed in Phase 1b Trial of AT-100 in Preterm Infants at Risk for Bronchopulmonary Dysplasia (BPD)

By asianet

— Novel preventative AT-100 offers potential to reduce incidence and severity of serious respiratory disease BPD, improving outcomes in very preterm infants Airway Therapeutics ( https://c212.net/c/link/?t=0&l=en&o=3489603-1&h=4231491452&u=https%3A%2F%2Fwww.airwaytherapeutics.com%2F&a=Airway+Therapeutics ), Inc. (Airway), a biopharmaceutical company developing a new class of biologics to break the cycle of injury and inflammation for patients with respiratory and inflammatory diseases, announced dosing … Continued

FDI World Dental Federation launches Consensus Statement on sustainable oral healthcare

By asianet

Paving the way for an industry Code of Good Practice – Picture is available at AP Images (http://www.apimages.com) – FDI World Dental Federation (FDI), today, launched its inaugural Consensus Statement on Environmentally Sustainable Oral Healthcare [ https://www.fdiworlddental.org/sustainability-consensus-statement ], aimed at moving the oral healthcare sector towards more environmentally friendly practices that ultimately reduce the carbon … Continued